cbd business funding — mellow

mellow is not a lender and does not underwrite or approve anything itself. we review your details and work to connect you with funding providers who serve your category. terms and approval come from the provider, subject to underwriting.

know the business type, state, time in business, monthly business-bank-deposit range, requested amount, exact use, existing advances or loan payments, and timeline. use actual operating deposits rather than projected sales.

possible structures include bank or credit-union products, lines of credit, term products, equipment or inventory financing, and revenue-based financing. eligibility, cost, collateral, guarantees, repayment, and disclosures vary. a category list is not evidence that a product is available.

no. the public inquiry is not a secure document channel. do not submit bank statements, identification, tax records, account credentials, ownership documents, or supplier records unless an appropriate counterparty and secure process have first been verified.

compare the amount received, total payback, payment amount and frequency, term or estimated duration, reconciliation rights, collateral or receivables involved, personal guarantees, prepayment and default provisions, broker compensation, and required state disclosures.

no — nothing is approved until a provider underwrites your file. what you qualify for depends on your deposits, time in business, existing obligations, product mix, and state. the inquiry is how we find out which providers fit.

some providers will still consider the category, and some have stepped back from it. the federal change affects which products can lawfully be sold, not whether a retailer can be underwritten. what providers look at is deposit history and how much of it depends on products the new definition removes — a store with revenue spread across compliant CBD, topicals, kratom, kava, and accessories reads differently than one concentrated in delta-8. a written transition plan helps an underwriter read a revenue change as a plan rather than a decline. none of that promises availability; eligibility, cost, and terms remain subject to each provider's underwriting.

a provider decides after underwriting, and in this vertical the recent months carry unusual weight. revenue-based providers commonly size an offer from average monthly business-bank deposits over a recent period, then reduce it for existing advances, negative days, and uneven deposits. some are also discounting deposits that clearly come from products the federal change removes, which can make the offer smaller than the statements alone suggest. bank and credit-union products look at time in business, credit, collateral, and payment coverage. know your deposit range, your product-mix split, your existing payments, and the exact amount and purpose before applying.

not for every structure, but time in business is an early screen. many revenue-based providers want at least 3 to 6 months of operating history and business-bank statements, while bank, credit-union, and SBA-backed products usually want 2 years or more. the screen runs on the legal entity and the business bank account, so a shop that reorganized or opened a new entity for a rebrand may read as newer than it is. if you plan to convert the store, keeping the same entity, location, and bank account generally preserves the operating history a provider can see.

that is a legal question with a hard date, and it should go to counsel rather than to a financing decision. product that falls outside the new federal definition on the effective date cannot be treated as ordinary retail stock afterward, and state law may add its own rules about holding, transferring, or destroying it. the planning work is knowing which stock is affected, what a realistic sell-through price looks like when every shop in the market discounts at once, and whether your suppliers will take returns. do that arithmetic before assuming financing can bridge whatever the sell-through does not cover.

it could, but nothing has moved it yet. in august 2026 the senate passed a 30-day delay that would shift the effective date to december 11, 2026; that measure is not law. as drafted it also would not extend to converted or synthetic cannabinoids, which covers most commercially sold delta-8 — that inventory would still change on november 12, 2026 even if the delay were enacted. separate bills to repeal or postpone section 781 have been introduced and have not advanced. the practical approach is to plan against november 12, 2026 and treat any change as room you did not count on.

disclose it before anything else. providers verify existing positions in bank statements, and an undisclosed advance can end a file and may breach the agreement already in place. some providers will consider an additional position and many will not, and in this vertical several are more cautious than usual because the revenue base is changing. run the arithmetic first: add the payments you already carry to what a new position would add, then check whether the store still covers rent, payroll, and the reformulated restock through a month with lower sales.

yes. the ban changed which products are legal to sell, not whether hemp retailers can be funded. specialty funders are still approving CBD and hemp stores — what they underwrite is your bank deposits, and what they want to see is a plan for the november 12, 2026 transition. shops with revenue concentrated in delta-8 or THCA should apply while that revenue still shows in their statements, because the trailing 3 months drive the offer.

no. non-intoxicating CBD that meets the new total-THC threshold and the 0.4 milligram per-container cap stays federally legal — broad-spectrum, isolate, and topicals formulated under the limit. what ends on november 12, 2026 is the intoxicating side: delta-8, THCA flower, HHC, and THC products above the caps. a CBD store built on compliant products keeps operating; one built on intoxicating hemp needs a new revenue plan.

product above the new limits becomes a schedule I controlled substance on november 12, 2026 — after that date it cannot legally be sold or even possessed without DEA licensure. that makes sell-through planning a hard deadline, not a suggestion. options before the date: discount and sell through, negotiate returns with suppliers, or exit the category early while prices hold. we fund the bridge either way.

yes. reformulation is one of the main uses we are funding in this vertical: compliant inventory buys, lab testing, new labeling, and the marketing to reintroduce the line. the per-container cap of 0.4 milligrams total THC means most full-spectrum consumables need reformulating, and suppliers are quoting long lead times as everyone reformulates at once. capital in hand lets you get in the queue early.

specialty funders offer $10K to $500K, and hemp retail deals commonly land between $30,000 and $100,000 — the vertical skews higher because reformulation and rebranding are more expensive than a simple restock. the amount is driven by your monthly deposits and consistency. shops applying before their hemp revenue drops typically qualify for more than the same shop applying after.

before. funders underwrite your trailing 3 months of bank statements. a hemp retailer applying in mid-2026 with strong deposits presents a fundable file; the same shop applying in december 2026, after the ban date, shows a falling revenue line that narrows options and shrinks offers. if you know the gap is coming, the strongest move is securing capital while the statements still show the old numbers.

a smaller set do, and knowing which ones is most of the value we add. some funders exited the category when section 781 passed. the ones still active want to see diversified deposits or a credible pivot plan, and several price for the transition risk. we send hemp files only to funders currently approving the category, which saves you declines and wasted credit pulls.

that is a fundable plan. shops are converting to smoke shop formats, wellness retail, kratom and kava bars, and accessory-forward stores. funders underwrite your deposits and your continuity as an operator — same entity, same location, same bank account all help. we package the file with the conversion plan spelled out, so the funder reads a pivot instead of a decline-worthy revenue dip.

two bills would change the timeline: H.R. 6209 would repeal section 781 entirely, and H.R. 7024 would push the effective date to 2029. neither has advanced out of committee, and the house agriculture committee moved the 2026 farm bill forward without a delay provision. plan around november 12, 2026 and treat a delay as upside. we would rather you hold capital you did not need than need capital you cannot get.

banks mostly say no, and the november 2026 federal hemp ban has made underwriters more cautious, not less. specialty funders still approve hemp and cbd retailers — they look at deposit consistency and how much revenue depends on products the ban removes. typical decision in 24-72 hours, subject to underwriting.